KOSZTYU, Pavlína, Iva SLANINOVÁ, Barbora VALČÍKOVÁ, Amandine VERLANDE, Petr MÜLLER, Jan PALEČEK a Stjepan ULDRIJAN. A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize. Frontiers in Physiology. Lausanne: Frontiers Media, 2019, roč. 10, APR 9 2019, s. 1-14. ISSN 1664-042X. Dostupné z: https://dx.doi.org/10.3389/fphys.2019.00390.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize
Autoři KOSZTYU, Pavlína (203 Česká republika, domácí), Iva SLANINOVÁ (203 Česká republika, domácí), Barbora VALČÍKOVÁ (203 Česká republika, domácí), Amandine VERLANDE (250 Francie, domácí), Petr MÜLLER (203 Česká republika), Jan PALEČEK (203 Česká republika, domácí) a Stjepan ULDRIJAN (203 Česká republika, garant, domácí).
Vydání Frontiers in Physiology, Lausanne, Frontiers Media, 2019, 1664-042X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30105 Physiology
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.367
Kód RIV RIV/00216224:14110/19:00108048
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3389/fphys.2019.00390
UT WoS 000463960200001
Klíčová slova anglicky Mdm2; Mdm4; MdmX; RING domain ubiquitin protein ligase; dimerization; mutagenesis; E3; p53
Štítky 14110513, podil, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Pavla Foltynová, Ph.D., učo 106624. Změněno: 31. 3. 2020 22:09.
Anotace
Mdm2 and MdmX are related proteins serving in the form of the Mdm2 homodimer or Mdm2/MdmX heterodimer as an E3 ubiquitin ligase for the tumor suppressor p53. The dimerization is required for the E3 activity and is mediated by the conserved RING domains present in both proteins, but only the RING domain of Mdm2 can form homodimers efficiently. We performed a systematic mutational analysis of human Mdm2, exchanging parts of the RING with the corresponding MdmX sequence, to identify the molecular determinants of this difference. Mdm2 can also promote MdmX degradation, and we identified several mutations blocking it. They were located mainly at the Mdm2/E2 interface and did not disrupt the MdmX-Mdm2 interaction. Surprisingly, some mutations of the Mdm2/E2 interface inhibited MdmX degradation, which is mediated by the Mdm2/MdmX heterodimer, but did not affect p53 degradation, mediated by the Mdm2 homodimer. Only one mutant, replacing a conserved cysteine 449 with asparagine (C449N), disrupted the ability of Mdm2 to dimerize with MdmX. When we introduced the cysteine residue into the corresponding site in MdmX, the RING domain became capable of forming dimers with other MdmX molecules in vivo, suggesting that one conserved amino acid residue in the RINGs of Mdm2 and MdmX could serve as the determinant of the differential ability of these domains to form dimers and their E3 activity. In immunoprecipitations, however, the homodimerization of MdmX could be observed only when the asparagine residue was replaced with cysteine in both RINGs. This result suggested that heterocomplexes consisting of one mutated MdmX RING with cysteine and one wild-type MdmX RING with asparagine might be less stable, despite being readily detectable in the cell-based assay. Moreover, Mdm2 C449N blocked Mdm2-MdmX heterodimerization but did not disrupt the ability of Mdm2 homodimer to promote p53 degradation, suggesting that the effect of the conserved cysteine and asparagine residues on dimerization was context-specific. Collectively, our results indicate that the effects of individual exchanges of conserved residues between Mdm2 and MdmX RING domains might be context-specific, supporting the hypothesis that Mdm2 RING homodimers and Mdm2-MdmX heterodimers may not be entirely structurally equivalent, despite their apparent similarity.
Návaznosti
GA14-12166S, projekt VaVNázev: Regulace dráhy nádorového supresoru p53 novými vazebnými partnery onkogenů Mdm2 a Mdm4
Investor: Grantová agentura ČR, Regulace dráhy nádorového supresoru p53 novými vazebnými partnery onkogenů Mdm2 a Mdm4
MUNI/A/0754/2017, interní kód MUNázev: Buněčná a molekulární biologie
Investor: Masarykova univerzita, Buněčná a molekulární biologie, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty
MUNI/A/1087/2018, interní kód MUNázev: Molekulární a buněčná biologie pro biomedicínské vědy
Investor: Masarykova univerzita, Molekulární a buněčná biologie pro biomedicínské vědy, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty
MUNI/M/0822/2015, interní kód MUNázev: Expressive Visualization of Protein Complexes
Investor: Masarykova univerzita, Expressive Visualization of Protein Complexes, INTERDISCIPLINARY - Mezioborové výzkumné projekty
VytisknoutZobrazeno: 18. 7. 2024 20:22